Navigation Links
Hyderabad To Have Asia’s First Catheter Making Uni

Hyderabad capital of Andhra Pradesh is set to house Asia's first catheter manufacturing facility, which will not only bring down the cost of catheter// based disposables but could also become an outsourcing hub for multinational companies.

Relisys Medical Devices Limited, a seven-year old company, Tuesday announced that the facility would be ready by December. Trial production is slated to begin by January next year.

The Rs.80 million facility, coming up at Manglapalli village in neighbouring Ranga Reddy district, will have the capacity to produce half a million catheter-based products annually.

To be developed as per US Food and Drug Administration (FDA) norms, it will produce 150,000 to 200,000 diagnostic catheters and 60,000 to 70,000 interventional catheters, used to pass stents to cardiac arteries.

N. Krishna Reddy, cardiologist and chairperson of Relisys, told reporters that Andhra Bank had come forward to extend a term loan of Rs.45 million for the facility.

He later told IANS that the facility would be a big boost to development of medical devices in a country, which presently produces only IV sets. "From the lowest level we are jumping to the sixth level," he said.

Krishna Reddy hoped the facility would cut the prices of catheters by 50 to 70 percent. India imports catheters at prices ranging from Rs.400 to Rs.3,000.

"This facility can not only cater to the region but also become an outsourcing hub for MNCs," he said.

The company also announced the launching of international multi-centre clinical trials of the new version of drug eluting cobalt-chromium stent coated with porous carbon-carbon nano-matrix.

Clinical trials would be conducted at nine centres in India as well as in Brazil, South Korea, Italy and Japan. The company has entered into a worldwide licensing agreement with Blue Membranes GmbH, Germany, for carbon-based drug delivery platform.

The use of porous carbon-carbon nano particle coating will eliminate the use of polymer based platform, thus completely reducing tissue inflammation and reaction (in cardiac arteries).

"Blue-Membranes will enforce the collaboration with Relisys that enables us to exploit our drug-delivery technology. We also aim to integrate manufacturing capabilities of Relisys to provide high quality manufacturing services for integrated solutions," said Soheil Asgari, CEO of Blue-Membranes.

Animal trials of this version of advanced drug eluting stent were recently completed at the Cardiovascular Research Institute, Washington.

The company had earlier completed clinical trials for its first generation drug eluting stent at All India Institute of Medical Sciences, New Delhi, Military Hospital, Pune, and Care Hospital, Hyderabad. More than 500 stents have been used since evaluation was completed six months ago.

Source: IANS


'"/>




Related medicine news :

1. Hyderabad Firm To Manufacture Tamiflu In India
2. Biotechnology Initiatives Planned In Hyderabad
3. US Consulate to Start Hyderabad Operations Next Year
4. First Vaccine Designed for Africa Cleared for Testing in Humans
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. First human clone is near
7. First Artificial Heart patient has Major setback
8. First head-to-head trials of once weekly Fosamax and Actonel therapies
9. WHO Declares Vietnam First Country to Control SARS
10. Russia Reports First SARS Case
11. Hope for First New Melanoma Treatment in Decades
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... ... 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett is ... these scholarships is to encourage applicants to pursue a degree in their field of ... parishes. , “We have available jobs in St. Landry and Evangeline Parishes that ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... cycle of pharmaceutical products, garnering increased attention from all stakeholders in the development ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... announced that nominations have closed for the ISE Southeast Awards 2016. Finalists and ... announced at the ISE® Southeast Executive Forum and Awards Gala on March 15, ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher ... Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare ... System. This will be the first Fisher House in Nevada, and will provide ...
(Date:2/12/2016)... ... February 12, 2016 , ... Erlanger Agency has announced a new partnership in ... latest campaign focuses on the fight against breast cancer, fundraising for a local woman ... here . , Carmen is a loving single mother of two boys who also ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Stem cells are primitive cells found in all multi-cellular ... to differentiate into mature cell types Stem cells are ... embryonic stem cells were derived from embryos in 1981, ... culturing of embryonic stem cells from non-human primates occurred ... As a result of these discoveries, stem cells can ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
(Date:2/11/2016)...   Health 2.0 , the premiere showcase and ... today " 10 Year Global Retrospective ", a platform ... past ten years.   --> ... has served as the preeminent thought-leader in the health ... technologies, companies, innovators, and patient-activists through an array of ...
Breaking Medicine Technology: